3rd Circuit Ocaliva news shows cirrhosis and liver failure across New Jersey, Pennsylvania, and Delaware. While the full extent of organ damage continues to emerge, MDL compensation is now being sought for Primary Biliary Cholangitis (PBC) victims.
To learn more, please see our information on claiming a 3rd Circuit Ocaliva settlement.
New Jersey Ocaliva News
New Jersey Ocaliva news reports indicate widespread liver damage.
- NJ Ocaliva News Reports – Coming Soon / As Available
If you were harmed by PBC medication, contact us about filing a New Jersey Ocaliva lawsuit.
Pennsylvania Ocaliva News
Pennsylvania Ocaliva news reports indicate widespread liver damage.
- PA Ocaliva News Reports – Coming Soon / As Available
If you were harmed by PBC medication, contact us about filing a Pennsylvania Ocaliva lawsuit.
Delaware Ocaliva News
Delaware Ocaliva news reports indicate widespread liver damage.
- DE Ocaliva News Reports – Coming Soon / As Available
If you were harmed by PBC medication, contact us about filing a Delaware Ocaliva lawsuit.
3rd Circuit Ocaliva News of Liver Damage MDL
3rd Circuit Ocaliva news of liver damage has raised concerns for Primary Biliary Cholangitis patients in New Jersey, Pennsylvania, and Delaware. As such, public support is growing for the court’s certification of an Ocaliva Multi-District Litigation (MDL) to administer claims. (Follow this link for our complete coverage of the Ocaliva MDL)
Liver Attorneys Act on 3rd Circuit Ocaliva News of Cirrhosis
Reporting cirrhosis is an important first step to justice. If your PBC medication caused liver damage, contact us about filing a 3rd Circuit Ocaliva MDL claim.
For FAQ about liver damage litigation, please see our Ocaliva lawyers homepage.